Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16687422 | 0.83 | ALDH1A3 (0.36) | ALDH1A3ERN1TYR | |
| SCHEMBL9945972 | 0.81 | ALDH1A3 (0.37) | ALDH1A3ERN1TYRCYP1A2MAPT | |
| SCHEMBL13429930 | 0.81 | ALDH1A3 (0.37) | ALDH1A3ERN1TYRCYP1A2MAPT | |
| SCHEMBL12514805 | 0.80 | ALDH1A3 (0.36) | ALDH1A3ERN1TYR | |
| SCHEMBL21413070 | 0.79 | ALDH1A3 (0.38) | ALDH1A3ALDH1A1TSHRERN1TYR | |
| SCHEMBL10132652 | 0.76 | ERN1 (0.40) | ALDH1A3ALDH1A1ERN1CYP1A2MAPT | |
| SCHEMBL1598490 | 0.75 | TSHR (0.50) | ALDH1A3ALDH1A1TSHRERN1CYP1A2 | |
| SCHEMBL27928228 | 0.74 | ALDH1A1 (0.38) | ALDH1A3ALDH1A1TSHRERN1MAPT | |
| SCHEMBL3321491 | 0.73 | ALDH1A1 (0.44) | ALDH1A1TSHRERN1TYRCYP1A2 | |
| SCHEMBL29581599 | 0.72 | SCN4A (0.37) | ALDH1A3ALDH1A1TSHRCYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9318706-B2 | Laminated structure, method for producing same, and electronic element comprising same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-04-19 | — | — | US | disclosed |
| US-20110177312-A1 | LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110177312-A1 | LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME | EPCAM, ITGA1, ITGB1 | ALDH1A3 1388/4885ALDH1A1 618/4885TSHR 4526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.